Results 21 to 30 of about 175,055 (304)

Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma. [PDF]

open access: yes, 2014
BackgroundCanine cutaneous T-cell lymphoma (CTCL) is an uncommon disease for which efficacious therapies are lacking. The novel anticancer nucleotide prodrug VDC-1101 (formerly known as GS-9219) has shown efficacy in dogs with multicentric lymphoma.
Burgess, KE   +5 more
core   +2 more sources

Follow up of utility and value of totally implantable chemotherapy catheter in 233 brazilian patients receiving chemotherapy to treat cancer [PDF]

open access: yesRevista do Colégio Brasileiro de Cirurgiões, 2023
Objectives: the present study aims to evaluate cancer patients related to the catheter flow and the general satisfaction of these patients. Methods: we studied 233 individuals diagnosed with cancer who underwent chemotherapy treatment through venous ...
RODRIGO MELO CÉSAR   +2 more
doaj   +1 more source

European surveillance of infections in cancer patients - ESIC [PDF]

open access: yes, 1999
Major advances in cancer therapy result from development of multidrug chemotherapy regimens. Besides death from tumor progression, infections are currently one of the major causes of mortality and morbidity.
Buchheidt, D.   +7 more
core   +1 more source

Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer [PDF]

open access: yes, 2015
Anaplastic thyroid cancer (ATC) is often incurable so new therapeutic approaches are needed. Tyrosine kinases inhibitors (such as imanitib, sunitinib or sorafenib) are under evaluation for the treatment of ATC.
Bond JA   +11 more
core   +1 more source

Evaluation of the permeation of antineoplastic agents through medical gloves of varying materials and thickness and with varying surface treatments

open access: yesJournal of Pharmaceutical Health Care and Sciences, 2017
Background Medical gloves are an important piece of personal protective equipment that prevents exposure to antineoplastic agents. The permeability of medical gloves to antineoplastic agents is a crucial factor in the appropriate selection of gloves ...
Toyohito Oriyama   +7 more
doaj   +1 more source

Translation inhibition by rocaglates is independent of eIF4E phosphorylation status [PDF]

open access: yes, 2016
Rocaglates are natural products that inhibit protein synthesis in eukaryotes and exhibit antineoplastic activity. In vitro biochemical assays, affinity chromatography experiments coupled with mass spectrometry analysis, and in vivo genetic screens have ...
Cencic, Regina   +4 more
core   +1 more source

Geographic Variations and Time Trends in Cancer Treatments in Taiwan

open access: yesBMC Public Health, 2017
Background Targeted therapies have become important treatment options for cancer care in many countries. This study aimed to examine recent trends in utilization of antineoplastic drugs, particularly the use of targeted therapies for treatment of cancer,
Jason C. Hsu   +2 more
doaj   +1 more source

Ocular complications of antineoplastic therapies

open access: yesFuture Science OA, 2023
Ocular complications of antineoplastic agents can have a profound effect on the quality of life of cancer patients. New oncologic treatments like monoclonal antibodies, immunotherapies, antibody-drug conjugates, checkpoint inhibitors and growth factor ...
Abbas Bader   +5 more
doaj   +1 more source

Natural killer cell response to chemotherapy-stressed cancer cells: Role in tumor immunosurveillance. [PDF]

open access: yes, 2017
Natural killer (NK) cells are innate cytotoxic lymphoid cells that actively prevent neoplastic development, growth, and metastatic dissemination in a process called cancer immunosurveillance.
Borrelli, Cristiana   +5 more
core   +1 more source

Extravasation of antineoplastic agents: prevention and treatments

open access: yesPediatric Reports, 2012
The extravasation of antineoplastic agents is an unwanted and distressing situation that can easily occur. It may cause severe and irreversible local injuries.
Rita Boschi, Elena Rostagno
doaj   +1 more source

Home - About - Disclaimer - Privacy